Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A)

International Journal of Antimicrobial Agents

Volumn 31, Issue 6, 2008, Pages 584-586

  Singh, Gaganmeet ^a   Chavan, Hemantkumar D ^a   Dey, Chinmoy S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4A; MILTEFOSINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBIOTIC RESISTANCE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; LEISHMANIA DONOVANI; LEISHMANIASIS; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS;

ANIMALS; ANTIFUNGAL AGENTS; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EUKARYOTIC INITIATION FACTOR-4A; ISOELECTRIC FOCUSING; LEISHMANIA; PHOSPHORYLCHOLINE; PROTEOMICS; TRANSCRIPTION FACTORS;

EID: 43549088519     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.01.032     Document Type: Letter

References (10)

1. Pérez-Victoria F.J., Sánchez-Cañete M.P., Seifert K., Croft S.L., Sundar S., Castanys S., et al. Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug Resist Updat 9 (2006) 26-39
2. Bryceson A. Current issues in the treatment of visceral leishmaniasis. Med Microbiol Immunol 190 (2001) 81-84
3. Verma N.K., Singh G., and Dey C.S. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction. Exp Parasitol 116 (2007) 1-13
4. Drummelsmith J., Brochu V., Girard I., Meisser N., and Ouellette M. Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol Cell Proteomics 2 (2003) 146-155
5. Dhalia R., Reis C.R., Freire E.R., Rocha P.O., Katz R., Muniz J.R., et al. Translation initiation in Leishmania major: characterisation of multiple eIF4F subunit homologues. Mol Biochem Parasitol 140 (2005) 23-41
6. Pérez-Victoria F.J., Castanys S., and Gamarro F. Resistance to miltefosine in Leishmania donovani involves a defective inward translocation of the drug. Antimicrob Agents Chemother 47 (2003) 2397-2403
7. Pérez-Victoria F.J., Gamarro F., Ouellette M., and Castanys S. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance. J Biol Chem 278 (2003) 49965-49971
8. Skeiky Y.A., Kennedy M., Kaufman D., Borges M.M., Guderian J.A., Scholler J.K., et al. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J Immunol 161 (1998) 6171-6179
9. Barhoumi M., Tanner N.K., Banroques J., Linder P., and Guizani I. Leishmania infantum LeIF protein is an ATP-dependent RNA helicase and an eIF4A-like factor that inhibits translation in yeast. FEBS J 273 (2006) 5086-5100
10. Montero-Lomeli{dotless} M., Morais B.L.B., Figueiredo D.L., Neto D.C.S., Martins J.R.P., and Masuda C.A. The initiation factor eIF4A is involved in the response to lithium stress in Saccharomyces cerevisiae. J Biol Chem 277 (2002) 21542-21548